Environmental and genetic risk factors in the development of neuromyelitis optica

References

• Patterson SL, Goglin SE. Neuromyelitis optica. Rheum Dis Clin North Am. 2017;43(4):579–591.
   PubMed Web of Science ®Google Scholar
• Cacciaguerra L, Meani A, Mesaros S, et al. Brain and cord imaging features in neuromyelitis optica spectrum disorders. Ann Neurol. 2019;85(3):371–384.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Pittock SJ, Lucchinetti CF, et al. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology. 2007;68(8):603–605.
   PubMed Web of Science ®Google Scholar
• Sahraian MA, Moghadasi AN, Azimi AR, et al. Diagnosis and management of Neuromyelitis optica spectrum disorder (NMOSD) in Iran: A consensus guideline and recommendations. Mult Scler Relat Disord. 2017;18:144–151.
   PubMed Web of Science ®Google Scholar
• Moore RR, Tanner M. The latest diagnostic criteria and treatment options for neuromyelitis optica. JAAPA. 2019;32(7):1–6.
   PubMedGoogle Scholar
• Etemadifar M, Nasr Z, Khalili B, et al. Epidemiology of Neuromyelitis optica in the world: a systematic review and meta-analysis. Mult Scler Int. 2015;2015:174720.
   PubMedGoogle Scholar
• Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2112.
   PubMed Web of Science ®Google Scholar
• Jarius S, Paul F, Franciotta D, et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008;4(4):202–214.
   PubMedGoogle Scholar
• Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012;11(6):535–544.
   PubMed Web of Science ®Google Scholar
• Jarius S, Wildemann B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol. 2013;23(6):661–683.
   PubMed Web of Science ®Google Scholar
• van Pelt ED, Wong YY, Ketelslegers IA, et al. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4 -IgG versus MOG -IgG seropositive cases in the Netherlands. Eur J Neurol. 2016;23(3):580–587.
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189.
   PubMed Web of Science ®Google Scholar
• Ramanathan S, Dale RC, Brilot F. Anti -MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev. 2016;15(4):307–324.
   PubMed Web of Science ®Google Scholar
• Alvarenga MP, Schimidt S, Alvarenga RP. Epidemiology of neuromyelitis optica in Latin America. Mult Scler J Exp Transl Clin. 2017;3(3):2055217317730098.
   Google Scholar
• Papais-Alvarenga RM, Pereira FF, Bernardes MS, et al. Familial forms of multiple sclerosis and neuromyelitis optica at an MS center in Rio de Janeiro State, Brazil. J Neurol Sci. 2015;356(1–2):196–201.
   PubMed Web of Science ®Google Scholar
• Matiello M, Kim HJ, Kim W, et al. Familial neuromyelitis optica. Neurology. 2010;75(4):310–315.
   PubMed Web of Science ®Google Scholar
• Moosazadeh M, Esmaeili R, Nasehi MM, et al. Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis Iran. J Neurol. 2017;16(2):90–95.
   Web of Science ®Google Scholar
• Eskandarieh S, Sistany Allahabadi N, Sadeghi M, et al. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999–2015. BMC Neurol. 2018;18:15.
   PubMed Web of Science ®Google Scholar
• Eskandarieh S, Nedjat S, Abdollahpour I, et al. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study. Mult Scler Relat Disord. 2017;12:39–43.
   PubMed Web of Science ®Google Scholar
• McAlpine D. Familial neuromyelitis optica: its occurrence in identical twins. Brain. 1938;1:430–438.
   Google Scholar
• Ch’ien LT, Medieros MO, Belluomini JJ. et al. Neuromyelitis optica (devic’s syndrome) in two sisters. Clin Electroencephalography. 1982;13(1):36–39.
   PubMedGoogle Scholar
• Yamakawa K, Kuroda H, Fujihara K, et al. Familial neuromyelitis optica (devic’s syndrome) with late onset in Japan. Neurology. 2000;55(2):318–320.
   PubMed Web of Science ®Google Scholar
• Braley T, Mikol DD. Neuromyelitis optica in a mother and daughter. Arch Neurol. 2007;64(8):1189–1192.
   PubMedGoogle Scholar
• Yoshimine S, Sakai T, Ogasawara M, et al. Anti-aquaporin-4 antibody-positive familial neuromyelitis optica in mother and daughter. Jpn J Ophthalmol. 2011;55(6):647–650.
   PubMed Web of Science ®Google Scholar
• Deschamps R, Paturel L, Jeannin S, et al. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population. Mult Scler. 2011;17(1):24–31.
   PubMed Web of Science ®Google Scholar
• Blanco Y, Ercilla-González G, Llufriu S, et al. HLA-DRB1 typing in Caucasians patients with neuromyelitis optica. Rev Neurol. 2011;53(3):146–152.
   PubMed Web of Science ®Google Scholar
• Yoshimura S, Isobe N, Matsushita T, et al. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry. 2013;84(1):29–34.
   PubMed Web of Science ®Google Scholar
• Brill L, Mandel M, Karussis D, et al. Increased occurrence of anti-AQP4 seropositivity and unique HLA class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel. J Neuroimmunol. 2016;293:65–70.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Park HY, Kim E, et al. Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiol Dis. 2010;37(2):349–355.
   PubMed Web of Science ®Google Scholar
• Zhao GX, Liu Y, Li ZX, et al. Variants in the promoter region of CYP7A1 are associated with neuromyelitis optica but not with multiple sclerosis in the Han Chinese population. Neurosci Bull. 2013;29(5):525–530.
   PubMed Web of Science ®Google Scholar
• Dai Y, Li J, Zhong X, et al. IL2RA allele increases risk of neuromyelitis optica in Southern Han Chinese. Can J Neurol Sci. 2013;40(6):832–835.
   PubMed Web of Science ®Google Scholar
• Ainiding G, Kawano Y, Sato S, et al. Interleukin 2 receptor α chain gene polymorphisms and risks of multiple sclerosis and neuromyelitis optica in southern Japanese. J Neurol Sci. 2014;337(1–2):147–150.
   PubMed Web of Science ®Google Scholar
• Kim JY, Bae JS, Kim HJ, et al. CD58 polymorphisms associated with the risk of neuromyelitis optica in a Korean population. BMC Neurol. 2014;14:57.
   PubMed Web of Science ®Google Scholar
• Wei Q, Yanyu C, Rui L, et al. Human aquaporin 4 gene polymorphisms in Chinese patients with neuromyelitis optica. J Neuroimmunol. 2014;274(1–2):192–196.
   PubMed Web of Science ®Google Scholar
• Wang X, Yu T, Yan Q, et al. Significant association between Fc receptor-like 3 polymorphisms (−1901A>G and −658C>T) and neuromyelitis optica (NMO) susceptibility in the Chinese population. Mol Neurobiol. 2016;53(1):686–694.
   PubMed Web of Science ®Google Scholar
• Sato S, Yamamoto K, Matsushita T, et al. Copy number variations in multiple sclerosis and neuromyelitis optica. Ann Neurol. 2015;78(5):762–774.
   PubMed Web of Science ®Google Scholar
• Estrada K, Whelan CW, Zhao F, et al. A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica. Nat Commun. 2018;9(1):1929.
   PubMedGoogle Scholar
• Liang H, Gao W, Liu X, et al. The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population. J Neuroimmunol. 2019;337:577045.
   PubMed Web of Science ®Google Scholar
• Shahmohammadi S, Doosti R, Shahmohammadi A, et al. Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord. 2019;27:350–363.
   PubMed Web of Science ®Google Scholar
• Harrison SR, Li D, Jeffery LE, et al. Vitamin D, autoimmune disease and rheumatoid arthritis. Calcif Tissue Int. 2020;106(1):58-75.
   PubMed Web of Science ®Google Scholar
• Rosen Y, Daich J, Soliman I, et al. Vitamin D and autoimmunity. Scand J Rheumatol. 2016;45(6):439–447.
   PubMed Web of Science ®Google Scholar
• Illescas-Montes R, Melguizo-Rodríguez L, Ruiz C, et al. Vitamin D and autoimmune diseases. Life Sci. 2019;233:116744.
   PubMed Web of Science ®Google Scholar
• Kusumadewi W, Imran D, Witjaksono F, et al. Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients. Mult Scler Relat Disord. 2018;25:329–333.
   PubMedGoogle Scholar
• Tüzün E, Küçükhüseyin Ö, Kürtüncü M, et al. Reduced serum vitamin D levels in neuromyelitis optica. Neurol Sci. 2015;36(9):1701–1702.
   PubMed Web of Science ®Google Scholar
• Min JH, Waters P, Vincent A, et al. Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability. PLoS One. 2014;9(9):e107274.
   PubMed Web of Science ®Google Scholar
• Shan Y, Tan S, Zhang L, et al. Serum 25-hydroxyvitamin D3 is associated with disease status in patients with neuromyelitis optica spectrum disorders in south China. J Neuroimmunol. 2016;299:118–123.
   PubMed Web of Science ®Google Scholar
• Shaygannejad V, Maljaei MB, Bank SS, et al. Association between sun exposure, vitamin D intake, serum vitamin D level, and immunoglobulin G level in patients with neuromyelitis optica spectrum disorder. Int J Prev Med. 2018;9:68.
   PubMed Web of Science ®Google Scholar
• Simon KC, Schmidt H, Loud S, et al. Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis. Mult Scler. 2015;21(6):703–709.
   PubMed Web of Science ®Google Scholar
• Eskandarieh S, Nedjat S, Abdollahpour I, et al. Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study. Acta Neurol Belg. 2018;118(2):277–287.
   PubMed Web of Science ®Google Scholar
• Eskandarieh S, Naser Moghadasi A, Sahraiain MA, et al. Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder. Iran J Neurol. 2019;18(3):93–98.
   PubMed Web of Science ®Google Scholar
• Chusid MJ, Williamson SJ, Murphy JV, et al. Neuromyelitis optica (devic disease) following varicella infection. J Pediatr. 1979;95(5 Pt 1):737–738.
   PubMed Web of Science ®Google Scholar
• Mathew T, Thomas K, Shivde S, et al. Post herpes zoster infection neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2017;18:93–94.
   PubMed Web of Science ®Google Scholar
• Machado C, Amorim J, Rocha J, et al. Neuromyelitis optica spectrum disorder and varicella-zoster infection. J Neurol Sci. 2015;358(1–2):520–521.
   PubMed Web of Science ®Google Scholar
• El Otmani H, Rafai MA, Moutaouakil F, et al. Devic’s optic neuromyelitis and pulmonary tuberculosis. Rev Mal Respir. 2005;22(1 Pt 1):143–146.
   PubMed Web of Science ®Google Scholar
• Miranda de Sousa A, Puccioni-Sohler M, Dias Borges A, et al. Post-dengue neuromyelitis optica: case report of a Japanese-descendent Brazilian child. J Infect Chemother. 2006;12(6):396–398.
   PubMedGoogle Scholar
• Lana-Peixoto MA, Pedrosa D, Talim N, et al. Neuromyelitis optica spectrum disorder associated with dengue virus infection. J Neuroimmunol. 2018;318:53–55.
   PubMed Web of Science ®Google Scholar
• Tran C, Du Pasquier RA, Cavassini M, et al. Neuromyelitis optica following CMV primo-infection. J Intern Med. 2007;261(5):500–503.
   PubMed Web of Science ®Google Scholar
• Satoh S, Hoshi K, Watanabe M, et al. An autopsied case of postinfectious neuromyelitis optica in an 84-year-old man. Rinsho Shinkeigaku. 2011;51(8):583–589.
   PubMedGoogle Scholar
• Marin Collazo IV, Howe CL, Lucchinetti CF, et al. Neuromyelitis optica and herpes simplex virus 2: a viral trigger for aquaporin-4 autoimmunity? Neurologist. 2018;23(3):92–93.
   PubMed Web of Science ®Google Scholar
• Aspahan MC, Leonhard SE, Gomez RS, et al. Neuromyelitis optica spectrum disorder associated with Zika virus infection. Neurol Clin Pract. 2019;9(1):e1–e3.
   PubMedGoogle Scholar
• Bizzoco E, Lolli F, Repice AM, et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol. 2009;256(11):1891–1898.
   PubMed Web of Science ®Google Scholar
• Zhong X, Zhou Y, Lu T, et al. Infections in neuromyelitis optica spectrum disorder. J Clin Neurosci. 2018;47:14–19.
   PubMed Web of Science ®Google Scholar
• Koga M, Takahashi T, Kawai M, et al. A serological analysis of viral and bacterial infections associated with neuromyelitis optica. J Neurol Sci. 2011;300(1–2):19–22.
   PubMed Web of Science ®Google Scholar
• Graves J, Grandhe S, Weinfurtner K, et al. Protective environmental factors for neuromyelitis optica. Neurology. 2014;83(21):1923–1929.
   PubMed Web of Science ®Google Scholar
• Masuda S, Mori M, Arai K, et al. Epstein-Barr virus persistence and reactivation in neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2015;86(10):1137–1142.
   PubMed Web of Science ®Google Scholar
• Mori M. Association between multiple sclerosis or neuromyelitis optica and Epstein-Barr virus. Brain Nerve. 2015;67(7):881–890.
   PubMedGoogle Scholar
• Long Y, Gao C, Qiu W, et al. Helicobacter pylori infection in Neuromyelitis optica and multiple sclerosis. Neuroimmunomodulation. 2013;20(2):107–112.
   PubMed Web of Science ®Google Scholar
• Li R, Zhong X, Qiu W, et al. Association between neuromyelitis optica and tuberculosis in a Chinese population. BMC Neurol. 2014;14:33.
   PubMed Web of Science ®Google Scholar
• Slavin YN, Bo M, Caggiu E, et al. High levels of antibodies against PtpA and PknG secreted by Mycobacterium avium ssp. paratuberculosis are present in neuromyelitis optica spectrum disorder and multiple sclerosis patients. J Neuroimmunol. 2018;323:49–52.
   PubMed Web of Science ®Google Scholar
• Rezaeimanesh N, Razeghi Jahromi S, Ghorbani Z, et al. The association between dietary sugar intake and neuromyelitis optica spectrum disorder: A case-control study. Mult Scler Relat Disord. 2019;31:112–117.
   PubMed Web of Science ®Google Scholar
• Rezaeimanesh N, Jahromi SR, Ghorbani Z, et al. Various types of dietary sugar and neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2018;26: 244–244.
   Google Scholar
• Rezaeimanesh N, Jahromi S, Ghorbani Z, et al. Low carbohydrate diet score and neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2018;26: 245–245.
   Google Scholar
• Rezaeimanesh N, Jahromi SR, Ghorbani Z, et al. High dietary carbohydrate to protein ratio as a risk factor for neuromyelitis optica spectrum disorder: a case-control study. Mult Scler Relat Disord. 2018;24:843–844.
   Google Scholar
• Rezaeimanesh N, Razeghi Jahromi S, Naser Moghadasi A, et al. The possible protective effects of whole grains and legumes consumption against neuromyelitis optica spectrum disorder odds. Mult Scler Relat Disord. 2019;25: 449–449.
   Google Scholar
• Rezaeimanesh N, Razeghi Jahromi S, Naser Moghadasi A, et al. Dietary total antioxidant capacity and neuromyelitis optica spectrum disorder susceptibility. Nutr Food Sci. 2019. [Epub ahead of print]
   Google Scholar
• Rezaeimanesh N, Razeghi Jahromi S, Sahraian MA, et al. A higher intake of antioxidant from diet is associated with decreased odds of NMO-IgG seropositivity in neuromyelitis optica spectrum disorder patients. Mult Scler Relat Disord. 2019;25:837.
   Google Scholar